speb/financial-data huggingface dataset:
AIMD income_statement (annual, 2024-12-31) — Other Income Expense: -404690.00
AIMD balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 23748328.00
AIMD balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 23748328.00
AIMD cash_flow (annual, 2024-12-31) — Other Non Cash Items: 397332.00
AIMD cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 88996.00
AIMD balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 174418.00
AIMD balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 348945.00
AIMD income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -404690.00
AIMD balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 848615.00
AIMD balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
AIMD income_statement (annual, 2024-12-31) — Pretax Income: -14862361.00
AIMD cash_flow (annual, 2024-12-31) — Purchase Of PPE: -21331.00
AIMD balance_sheet (annual, 2024-12-31) — Raw Materials: 74875.00
AIMD balance_sheet (annual, 2024-12-31) — Receivables: 56.00
AIMD income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 52595.00
AIMD income_statement (annual, 2024-12-31) — Reconciled Depreciation: 4801716.00
AIMD cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1751754.00
AIMD cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -270000.00
AIMD cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
AIMD income_statement (annual, 2024-12-31) — Research And Development: 8413923.00
AIMD balance_sheet (annual, 2024-12-31) — Retained Earnings: -52749316.00
AIMD income_statement (annual, 2024-12-31) — Selling General And Administration: 5395415.00
AIMD balance_sheet (annual, 2024-12-31) — Share Issued: 3085477.00
AIMD cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3543101.00
AIMD balance_sheet (annual, 2024-12-31) — Stockholders Equity: 15516310.00
AIMD balance_sheet (annual, 2024-12-31) — Tangible Book Value: -8232018.00
AIMD income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
AIMD income_statement (annual, 2024-12-31) — Tax Provision: 800.00
AIMD income_statement (quarterly, 2024-12-31) — Tax Provision: 800.00
AIMD income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
AIMD balance_sheet (annual, 2024-12-31) — Total Assets: 28820199.00
AIMD balance_sheet (annual, 2024-12-31) — Total Capitalization: 24516310.00
AIMD balance_sheet (annual, 2024-12-31) — Total Debt: 12000000.00
AIMD balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 15516310.00
AIMD income_statement (annual, 2024-12-31) — Total Expenses: 13861933.00
AIMD balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 13303889.00
AIMD balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 24482391.00
AIMD balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 9348945.00
AIMD income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -13841204.00
AIMD income_statement (annual, 2024-12-31) — Total Other Finance Cost: 308336.00
AIMD income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 0.00
AIMD balance_sheet (annual, 2024-12-31) — Treasury Stock: 0.00
AIMD balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 0.00
AIMD cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 275624.00
AIMD cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
AIMD balance_sheet (annual, 2024-12-31) — Work In Process: 1131.00
AIMD balance_sheet (annual, 2024-12-31) — Working Capital: 382864.00
AIMD income_statement (quarterly, 2025-03-31) — +Operating Expense: 3250845.00
AIMD income_statement (quarterly, 2025-03-31) — +Total Revenue: 106207.00
AIMD balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 91.00
AIMD balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 69435008.00
AIMD income_statement (quarterly, 2025-03-31) — Basic Average Shares: 3172611.00
AIMD income_statement (quarterly, 2025-03-31) — Basic EPS: -1.04
AIMD cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 3892919.00
AIMD cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -33640.00
AIMD balance_sheet (quarterly, 2025-03-31) — Capital Stock: 172152.00
AIMD balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2628286.00
AIMD balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2628286.00
AIMD balance_sheet (quarterly, 2025-03-31) — Cash Financial: 2628286.00
AIMD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 14605.00
AIMD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -20587.00
AIMD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1224578.00
AIMD cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -55409.00
AIMD cash_flow (quarterly, 2025-03-31) — Change In Inventory: 1925.00
AIMD cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 20293.00
AIMD cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -55409.00
AIMD cash_flow (quarterly, 2025-03-31) — Change In Receivables: -35.00
AIMD cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -33226.00
AIMD cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -35.00
AIMD cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1230560.00
AIMD balance_sheet (quarterly, 2025-03-31) — Common Stock: 172152.00
AIMD balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 13121652.00
AIMD cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 14605.00
AIMD income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 18233.00
AIMD balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 523467.00
AIMD balance_sheet (quarterly, 2025-03-31) — Current Assets: 3050992.00
AIMD balance_sheet (quarterly, 2025-03-31) — Current Debt: 1000000.00
AIMD balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1000000.00
AIMD balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 0.00
AIMD balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 0.00
AIMD balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1523467.00
AIMD cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1177270.00
AIMD cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1177270.00
AIMD income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 3172611.00
AIMD income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.04
AIMD income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -3286022.00
AIMD income_statement (quarterly, 2025-03-31) — EBIT: -3105577.00
AIMD income_statement (quarterly, 2025-03-31) — EBITDA: -1928307.00
AIMD cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -34073.00
AIMD cash_flow (quarterly, 2025-03-31) — End Cash Position: 2628286.00
AIMD cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 14605.00
AIMD balance_sheet (quarterly, 2025-03-31) — Finished Goods: 66787.00
AIMD balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: -450170.00
AIMD cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1258218.00
AIMD balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -450170.00
AIMD balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 22633161.00
AIMD income_statement (quarterly, 2025-03-31) — Gross Profit: 87974.00
AIMD income_statement (quarterly, 2025-03-31) — Interest Expense: 180445.00
AIMD income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 180445.00
AIMD balance_sheet (quarterly, 2025-03-31) — Inventory: 141831.00
AIMD balance_sheet (quarterly, 2025-03-31) — Invested Capital: 25121652.00
AIMD cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -20587.00
AIMD cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 14605.00
AIMD cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
AIMD balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 11000000.00
AIMD balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 11000000.00
AIMD cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
AIMD cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 14605.00
AIMD balance_sheet (quarterly, 2025-03-31) — Net Debt: 9371714.00
AIMD income_statement (quarterly, 2025-03-31) — Net Income: -3286022.00
AIMD income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -3286022.00
AIMD income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -3286022.00
AIMD income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -3286022.00
AIMD income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -3286022.00
AIMD cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -3286022.00
AIMD income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -3286022.00
AIMD income_statement (quarterly, 2025-03-31) — Net Interest Income: -180445.00
AIMD cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
AIMD cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
AIMD income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -180445.00
AIMD cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 13053.00
AIMD balance_sheet (quarterly, 2025-03-31) — Net PPE: 494387.00
AIMD cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -33640.00
AIMD balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -9511509.00
AIMD income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1928307.00
AIMD income_statement (quarterly, 2025-03-31) — Normalized Income: -3286022.00
AIMD cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1224578.00
AIMD income_statement (quarterly, 2025-03-31) — Operating Income: -3162871.00
AIMD income_statement (quarterly, 2025-03-31) — Operating Revenue: 106207.00
AIMD balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 3443032.00
AIMD balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 280784.00
AIMD balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1000000.00
AIMD income_statement (quarterly, 2025-03-31) — Other Income Expense: 57294.00
AIMD cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 862230.00
AIMD balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 174536.00
AIMD balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 707957.00
AIMD income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 57294.00
AIMD balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 523467.00
AIMD balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
AIMD income_statement (quarterly, 2025-03-31) — Pretax Income: -3286022.00
AIMD cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -33640.00
AIMD balance_sheet (quarterly, 2025-03-31) — Raw Materials: 73928.00
AIMD balance_sheet (quarterly, 2025-03-31) — Receivables: 91.00
AIMD income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 18233.00
AIMD income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1177270.00
AIMD income_statement (quarterly, 2025-03-31) — Research And Development: 1724084.00
AIMD balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -56035338.00
AIMD cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
AIMD income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1526761.00
AIMD balance_sheet (quarterly, 2025-03-31) — Share Issued: 3443032.00
AIMD cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 55170.00
AIMD balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 13121652.00
AIMD balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -9511509.00
AIMD income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AIMD income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
AIMD income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
AIMD balance_sheet (quarterly, 2025-03-31) — Total Assets: 26353076.00
AIMD balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 24121652.00
AIMD balance_sheet (quarterly, 2025-03-31) — Total Debt: 12000000.00
AIMD balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 13121652.00
AIMD income_statement (quarterly, 2025-03-31) — Total Expenses: 3269078.00
AIMD balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 13231424.00
AIMD balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 23302084.00
AIMD balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 11707957.00
AIMD income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -3162871.00
AIMD cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 0.00
AIMD balance_sheet (quarterly, 2025-03-31) — Work In Process: 1116.00
AIMD balance_sheet (quarterly, 2025-03-31) — Working Capital: 1527525.00
AIMD income_statement (quarterly, 2025-06-30) — +Operating Expense: 3749413.00
AIMD income_statement (quarterly, 2025-06-30) — +Total Revenue: 4663.00
AIMD balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 187.00
AIMD balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 71668502.00
AIMD income_statement (quarterly, 2025-06-30) — Basic Average Shares: 4122131.00
AIMD income_statement (quarterly, 2025-06-30) — Basic EPS: -0.99
AIMD cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2628286.00
AIMD balance_sheet (quarterly, 2025-06-30) — Capital Stock: 42680.00
AIMD balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1223184.00
AIMD balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1223184.00
AIMD balance_sheet (quarterly, 2025-06-30) — Cash Financial: 1223184.00
AIMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -295507.00
AIMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 2542.00
AIMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1350422.00
AIMD cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 228954.00
AIMD cash_flow (quarterly, 2025-06-30) — Change In Inventory: -18226.00
AIMD cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -69765.00
AIMD cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 228954.00
AIMD cash_flow (quarterly, 2025-06-30) — Change In Receivables: -96.00
AIMD cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 140867.00
AIMD cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -96.00
AIMD cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1643387.00
AIMD balance_sheet (quarterly, 2025-06-30) — Common Stock: 42680.00
AIMD balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 11442786.00
AIMD cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 704753.00
AIMD income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 937.00
AIMD balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 602782.00
AIMD balance_sheet (quarterly, 2025-06-30) — Current Assets: 1733977.00
AIMD balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 0.00
AIMD balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 0.00
AIMD balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 602782.00
AIMD cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1194172.00
AIMD cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1194172.00
AIMD income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 4122131.00
AIMD income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.99
AIMD income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -4084990.00
AIMD income_statement (quarterly, 2025-06-30) — EBIT: -3907033.00
AIMD income_statement (quarterly, 2025-06-30) — EBITDA: -2712861.00
AIMD cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 238285.00
AIMD cash_flow (quarterly, 2025-06-30) — End Cash Position: 1223184.00
AIMD cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -295507.00
AIMD balance_sheet (quarterly, 2025-06-30) — Finished Goods: 75031.00
AIMD cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1342732.00
AIMD balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -148068.00
AIMD balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 21505821.00
AIMD income_statement (quarterly, 2025-06-30) — Gross Profit: 3726.00
AIMD income_statement (quarterly, 2025-06-30) — Interest Expense: 177957.00
AIMD income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 177957.00
AIMD balance_sheet (quarterly, 2025-06-30) — Inventory: 160057.00
AIMD balance_sheet (quarterly, 2025-06-30) — Invested Capital: 22442786.00
AIMD cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 2542.00
AIMD cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 704753.00
AIMD cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
AIMD balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 11000000.00
AIMD balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 11000000.00
AIMD cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
AIMD cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 704493.00
AIMD balance_sheet (quarterly, 2025-06-30) — Net Debt: 9776816.00
AIMD income_statement (quarterly, 2025-06-30) — Net Income: -4084990.00
AIMD income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -4084990.00
AIMD income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -4084990.00
AIMD income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -4084990.00
AIMD income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -4084990.00
AIMD cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -4084990.00
AIMD income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -4084990.00
AIMD income_statement (quarterly, 2025-06-30) — Net Interest Income: -177957.00
AIMD cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1000000.00
AIMD cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -1000000.00
AIMD income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -177957.00
AIMD cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -5148.00
AIMD balance_sheet (quarterly, 2025-06-30) — Net PPE: 495109.00
AIMD cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 7690.00
AIMD balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -10063035.00
AIMD income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2712861.00
AIMD income_statement (quarterly, 2025-06-30) — Normalized Income: -4084990.00
AIMD cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1350422.00
AIMD income_statement (quarterly, 2025-06-30) — Operating Income: -3745687.00
AIMD income_statement (quarterly, 2025-06-30) — Operating Revenue: 4663.00
AIMD balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 4267990.00
AIMD balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 350549.00
AIMD balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -148068.00
AIMD income_statement (quarterly, 2025-06-30) — Other Income Expense: -161346.00
AIMD cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 75000.00
AIMD balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 187269.00
AIMD balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 876608.00
AIMD income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -161346.00
AIMD balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 602782.00
AIMD balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
AIMD income_statement (quarterly, 2025-06-30) — Pretax Income: -4084990.00
AIMD cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 7690.00
AIMD balance_sheet (quarterly, 2025-06-30) — Raw Materials: 83761.00
AIMD balance_sheet (quarterly, 2025-06-30) — Receivables: 187.00
AIMD income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 937.00
AIMD income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1194172.00
AIMD income_statement (quarterly, 2025-06-30) — Research And Development: 1911800.00
AIMD balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -60120328.00
AIMD income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1837613.00
AIMD balance_sheet (quarterly, 2025-06-30) — Share Issued: 4267990.00
AIMD cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1324529.00
AIMD balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 11442786.00
AIMD balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -10063035.00
AIMD income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AIMD income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
AIMD income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
AIMD balance_sheet (quarterly, 2025-06-30) — Total Assets: 23922176.00
AIMD balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 22442786.00
AIMD balance_sheet (quarterly, 2025-06-30) — Total Debt: 11000000.00
AIMD balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 11442786.00
AIMD income_statement (quarterly, 2025-06-30) — Total Expenses: 3750350.00
AIMD balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 12479390.00
AIMD balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 22188199.00
AIMD balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 11876608.00
AIMD income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3745687.00
AIMD cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 0.00
AIMD balance_sheet (quarterly, 2025-06-30) — Work In Process: 1265.00
AIMD balance_sheet (quarterly, 2025-06-30) — Working Capital: 1131195.00
AIMD income_statement (quarterly, 2025-09-30) — +Operating Expense: 2785883.00
AIMD income_statement (quarterly, 2025-09-30) — +Total Revenue: 2167.00
AIMD balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 62.00
AIMD balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 73263397.00
AIMD income_statement (quarterly, 2025-09-30) — Basic Average Shares: 4554359.00
AIMD income_statement (quarterly, 2025-09-30) — Basic EPS: -0.64
AIMD cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1223184.00
AIMD cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -10140.00
AIMD balance_sheet (quarterly, 2025-09-30) — Capital Stock: 48065.00
AIMD balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1128217.00
AIMD balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1128217.00
AIMD balance_sheet (quarterly, 2025-09-30) — Cash Financial: 1128217.00
AIMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 1133537.00
AIMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 4933.00
AIMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1184679.00
AIMD cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 155544.00
AIMD cash_flow (quarterly, 2025-09-30) — Change In Inventory: -6826.00
AIMD cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -31817.00
AIMD cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 155544.00
AIMD cash_flow (quarterly, 2025-09-30) — Change In Receivables: 125.00
AIMD cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 117026.00
AIMD cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 125.00
AIMD cash_flow (quarterly, 2025-09-30) — Changes In Cash: -46209.00
AIMD balance_sheet (quarterly, 2025-09-30) — Common Stock: 48065.00
AIMD balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 10044949.00
AIMD cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 1133537.00
AIMD cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
AIMD income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 477.00
AIMD balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 581356.00
AIMD balance_sheet (quarterly, 2025-09-30) — Current Assets: 1720915.00
AIMD balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 0.00
AIMD balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 0.00
AIMD balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 581356.00
AIMD cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1206641.00
AIMD cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1206641.00
AIMD income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 4554359.00
AIMD income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.64
AIMD income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2931702.00
AIMD income_statement (quarterly, 2025-09-30) — EBIT: -2755118.00
AIMD income_statement (quarterly, 2025-09-30) — EBITDA: -1548477.00
AIMD cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -48758.00
AIMD cash_flow (quarterly, 2025-09-30) — End Cash Position: 1128217.00
AIMD cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 1133537.00
AIMD balance_sheet (quarterly, 2025-09-30) — Finished Goods: 71593.00
AIMD cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1194819.00
AIMD balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -214483.00
AIMD balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 20365899.00
AIMD income_statement (quarterly, 2025-09-30) — Gross Profit: 1690.00
AIMD income_statement (quarterly, 2025-09-30) — Interest Expense: 176584.00
AIMD income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 176584.00
AIMD balance_sheet (quarterly, 2025-09-30) — Inventory: 166883.00
AIMD balance_sheet (quarterly, 2025-09-30) — Invested Capital: 21044949.00
AIMD cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 4933.00
AIMD cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 1133537.00
AIMD cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
AIMD balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 11000000.00
AIMD balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 11000000.00
AIMD cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
AIMD cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
AIMD cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 1133537.00
AIMD balance_sheet (quarterly, 2025-09-30) — Net Debt: 9871783.00
AIMD income_statement (quarterly, 2025-09-30) — Net Income: -2931702.00
AIMD income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2931702.00
AIMD income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2931702.00
AIMD income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2931702.00
AIMD income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2931702.00
AIMD cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2931702.00
AIMD income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2931702.00
AIMD income_statement (quarterly, 2025-09-30) — Net Interest Income: -176584.00
AIMD cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
AIMD cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
AIMD income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -176584.00
AIMD cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 15073.00
AIMD balance_sheet (quarterly, 2025-09-30) — Net PPE: 414558.00
AIMD cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -10140.00
AIMD balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -10320950.00
AIMD income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1548477.00
AIMD income_statement (quarterly, 2025-09-30) — Normalized Income: -2931702.00
AIMD cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1184679.00
AIMD income_statement (quarterly, 2025-09-30) — Operating Income: -2784193.00
AIMD income_statement (quarterly, 2025-09-30) — Operating Revenue: 2167.00
AIMD balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 4793797.00
AIMD balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 425753.00
AIMD balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -214483.00
AIMD income_statement (quarterly, 2025-09-30) — Other Income Expense: 29075.00
AIMD cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 75000.00
AIMD balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 177968.00
AIMD balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1053035.00
AIMD income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 29075.00
AIMD balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 581356.00
AIMD balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
AIMD income_statement (quarterly, 2025-09-30) — Pretax Income: -2931702.00
AIMD cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -10140.00
AIMD balance_sheet (quarterly, 2025-09-30) — Raw Materials: 94072.00
AIMD balance_sheet (quarterly, 2025-09-30) — Receivables: 62.00
AIMD income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 477.00
AIMD income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1206641.00
AIMD cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
AIMD cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
AIMD income_statement (quarterly, 2025-09-30) — Research And Development: 1990630.00
AIMD balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -63052030.00
AIMD income_statement (quarterly, 2025-09-30) — Selling General And Administration: 795253.00
AIMD balance_sheet (quarterly, 2025-09-30) — Share Issued: 4793797.00
AIMD cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 348356.00
AIMD balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 10044949.00
AIMD balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -10320950.00
AIMD income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AIMD income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
AIMD income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
AIMD balance_sheet (quarterly, 2025-09-30) — Total Assets: 22679340.00
AIMD balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 21044949.00
AIMD balance_sheet (quarterly, 2025-09-30) — Total Debt: 11000000.00
AIMD balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 10044949.00
AIMD income_statement (quarterly, 2025-09-30) — Total Expenses: 2786360.00
AIMD balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 12634391.00
AIMD balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 20958425.00
AIMD balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 12053035.00
AIMD income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -2784193.00
AIMD cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
AIMD balance_sheet (quarterly, 2025-09-30) — Work In Process: 1218.00
AIMD balance_sheet (quarterly, 2025-09-30) — Working Capital: 1139559.00
AIMD income_statement (annual, 2025-12-31) — +Operating Expense: 14093319.00
AIMD income_statement (quarterly, 2025-12-31) — +Operating Expense: 4307178.00
AIMD income_statement (annual, 2025-12-31) — +Total Revenue: 124157.00
AIMD income_statement (quarterly, 2025-12-31) — +Total Revenue: 11120.00
AIMD balance_sheet (annual, 2025-12-31) — Accounts Receivable: 22.00
AIMD balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 22.00
AIMD balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1410545.00
AIMD balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1410545.00
AIMD balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 77234374.00
AIMD balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 77234374.00
AIMD income_statement (annual, 2025-12-31) — Basic Average Shares: 4270815.00
AIMD income_statement (annual, 2025-12-31) — Basic EPS: -3.46
AIMD cash_flow (annual, 2025-12-31) — Beginning Cash Position: 3892919.00
AIMD cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1128217.00
AIMD cash_flow (annual, 2025-12-31) — Capital Expenditure: -34561.00
AIMD balance_sheet (annual, 2025-12-31) — Capital Stock: 69827.00
AIMD balance_sheet (quarterly, 2025-12-31) — Capital Stock: 69827.00
AIMD balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 417353.00
AIMD balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 417353.00
AIMD balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 417353.00
AIMD balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 417353.00
AIMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1008461.00
AIMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 155826.00
AIMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2223.00
AIMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 10889.00
AIMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -4614697.00
AIMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -855018.00
AIMD cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 1003536.00
AIMD cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 674447.00
AIMD cash_flow (annual, 2025-12-31) — Change In Inventory: -151809.00
AIMD cash_flow (quarterly, 2025-12-31) — Change In Inventory: -128682.00
AIMD cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -123085.00
AIMD cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -41796.00
AIMD cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1003536.00
AIMD cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 674447.00
AIMD cash_flow (annual, 2025-12-31) — Change In Receivables: 34.00
AIMD cash_flow (quarterly, 2025-12-31) — Change In Receivables: 40.00
AIMD cash_flow (annual, 2025-12-31) — Change In Working Capital: 728676.00
AIMD cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 504009.00
AIMD cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 34.00
AIMD cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 40.00
AIMD cash_flow (annual, 2025-12-31) — Changes In Cash: -3608459.00
AIMD cash_flow (quarterly, 2025-12-31) — Changes In Cash: -688303.00
AIMD balance_sheet (annual, 2025-12-31) — Common Stock: 69827.00
AIMD balance_sheet (quarterly, 2025-12-31) — Common Stock: 69827.00
AIMD balance_sheet (annual, 2025-12-31) — Common Stock Equity: 7562582.00
AIMD balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 7562582.00
AIMD cash_flow (annual, 2025-12-31) — Common Stock Issuance: 2008721.00
AIMD cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 155826.00
AIMD cash_flow (annual, 2025-12-31) — Common Stock Payments: -260.00
AIMD cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
AIMD income_statement (annual, 2025-12-31) — Cost Of Revenue: 21246.00
AIMD income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1599.00
AIMD balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 728683.00
AIMD balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 728683.00
AIMD balance_sheet (annual, 2025-12-31) — Current Assets: 1138799.00
AIMD balance_sheet (quarterly, 2025-12-31) — Current Assets: 1138799.00
AIMD balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 350000.00
AIMD balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 350000.00
AIMD balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 350000.00
AIMD balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 350000.00
AIMD balance_sheet (annual, 2025-12-31) — Current Liabilities: 1078683.00
AIMD balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1078683.00
AIMD cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 4780150.00
AIMD cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1202067.00
AIMD cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 4780150.00
AIMD cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1202067.00
AIMD income_statement (annual, 2025-12-31) — Diluted Average Shares: 4270815.00
AIMD income_statement (annual, 2025-12-31) — Diluted EPS: -3.46
AIMD income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -14771012.00
AIMD income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -4468298.00
AIMD income_statement (annual, 2025-12-31) — EBIT: -14058309.00
AIMD income_statement (quarterly, 2025-12-31) — EBIT: -4290581.00
AIMD income_statement (annual, 2025-12-31) — EBITDA: -9278159.00
AIMD income_statement (quarterly, 2025-12-31) — EBITDA: -3088514.00
AIMD cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 132893.00
AIMD cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -22561.00
AIMD cash_flow (annual, 2025-12-31) — End Cash Position: 417353.00
AIMD cash_flow (quarterly, 2025-12-31) — End Cash Position: 417353.00
AIMD cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1008461.00
AIMD cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 155826.00
AIMD balance_sheet (annual, 2025-12-31) — Finished Goods: 68958.00
AIMD balance_sheet (quarterly, 2025-12-31) — Finished Goods: 68958.00
AIMD balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -249291.00
AIMD balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -249291.00
AIMD cash_flow (annual, 2025-12-31) — Free Cash Flow: -4649258.00
AIMD cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -853489.00
AIMD cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -1096.00
AIMD balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -249291.00
AIMD balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -249291.00
AIMD balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 19226003.00
AIMD balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 19226003.00
AIMD balance_sheet (annual, 2025-12-31) — Gross PPE: 1753826.00
AIMD balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1753826.00
AIMD income_statement (annual, 2025-12-31) — Gross Profit: 102911.00
AIMD income_statement (quarterly, 2025-12-31) — Gross Profit: 9521.00
AIMD cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 800.00
AIMD income_statement (annual, 2025-12-31) — Interest Expense: 711903.00
AIMD income_statement (quarterly, 2025-12-31) — Interest Expense: 176917.00
AIMD income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 711903.00
AIMD income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 176917.00
AIMD cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 32.00
AIMD balance_sheet (annual, 2025-12-31) — Inventory: 295565.00
AIMD balance_sheet (quarterly, 2025-12-31) — Inventory: 295565.00
AIMD balance_sheet (annual, 2025-12-31) — Invested Capital: 18562582.00
AIMD balance_sheet (quarterly, 2025-12-31) — Invested Capital: 18562582.00
AIMD cash_flow (annual, 2025-12-31) — Investing Cash Flow: -2223.00
AIMD cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 10889.00
AIMD cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 2008721.00
AIMD cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 155826.00
AIMD cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
AIMD cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
AIMD balance_sheet (annual, 2025-12-31) — Long Term Debt: 11000000.00
AIMD balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 11000000.00
AIMD balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 11000000.00
AIMD balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 11000000.00
AIMD cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
AIMD cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
AIMD cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1000000.00
AIMD cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
AIMD balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1753826.00
AIMD balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1753826.00
AIMD cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 2008461.00
AIMD cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 155826.00
AIMD balance_sheet (annual, 2025-12-31) — Net Debt: 10582647.00
AIMD balance_sheet (quarterly, 2025-12-31) — Net Debt: 10582647.00
AIMD income_statement (annual, 2025-12-31) — Net Income: -14771012.00
AIMD income_statement (quarterly, 2025-12-31) — Net Income: -4468298.00
AIMD income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -14771012.00
AIMD income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -4468298.00
AIMD income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -14771012.00
AIMD income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -4468298.00
AIMD income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -14771012.00
AIMD income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -4468298.00
AIMD income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -14771012.00
AIMD income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -4468298.00
AIMD cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -14771012.00
AIMD cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -4468298.00
AIMD income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -14771012.00
AIMD income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -4468298.00
AIMD income_statement (annual, 2025-12-31) — Net Interest Income: -711903.00
AIMD income_statement (quarterly, 2025-12-31) — Net Interest Income: -176917.00
AIMD cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -1000000.00
AIMD cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
AIMD cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -1000000.00
AIMD cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
AIMD income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -711903.00
AIMD income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -176917.00
AIMD cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 32338.00
AIMD cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 9360.00
AIMD balance_sheet (annual, 2025-12-31) — Net PPE: 343281.00
AIMD balance_sheet (quarterly, 2025-12-31) — Net PPE: 343281.00
AIMD cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -34561.00
AIMD cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 1529.00
AIMD balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -11663421.00
AIMD balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -11663421.00
AIMD income_statement (annual, 2025-12-31) — Normalized EBITDA: -9278159.00
AIMD income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -3088514.00
AIMD income_statement (annual, 2025-12-31) — Normalized Income: -14771012.00
AIMD income_statement (quarterly, 2025-12-31) — Normalized Income: -4468298.00
AIMD cash_flow (annual, 2025-12-31) — Operating Cash Flow: -4614697.00
AIMD cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -855018.00
AIMD cash_flow (annual, 2025-12-31) — Operating Gains Losses: -1096.00
AIMD income_statement (annual, 2025-12-31) — Operating Income: -13990408.00
AIMD income_statement (quarterly, 2025-12-31) — Operating Income: -4297657.00
AIMD income_statement (annual, 2025-12-31) — Operating Revenue: 124157.00
AIMD income_statement (quarterly, 2025-12-31) — Operating Revenue: 11120.00
AIMD balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 5882675.00
AIMD balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 5882675.00
AIMD balance_sheet (annual, 2025-12-31) — Other Current Assets: 425859.00
AIMD balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 425859.00
AIMD income_statement (annual, 2025-12-31) — Other Income Expense: -67901.00
AIMD income_statement (quarterly, 2025-12-31) — Other Income Expense: 7076.00
AIMD balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 19226003.00
AIMD balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 19226003.00
AIMD cash_flow (annual, 2025-12-31) — Other Non Cash Items: 2920530.00
AIMD cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1908300.00
AIMD balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 163025.00
AIMD balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 163025.00
AIMD balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1229843.00
AIMD balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1229843.00
AIMD income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -67901.00
AIMD income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 7076.00
AIMD balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 728683.00
AIMD balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 728683.00
AIMD balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
AIMD balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
AIMD income_statement (annual, 2025-12-31) — Pretax Income: -14770212.00
AIMD income_statement (quarterly, 2025-12-31) — Pretax Income: -4467498.00
AIMD cash_flow (annual, 2025-12-31) — Purchase Of PPE: -34561.00
AIMD cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 1529.00
AIMD balance_sheet (annual, 2025-12-31) — Raw Materials: 118329.00
AIMD balance_sheet (quarterly, 2025-12-31) — Raw Materials: 118329.00
AIMD balance_sheet (annual, 2025-12-31) — Receivables: 22.00
AIMD balance_sheet (quarterly, 2025-12-31) — Receivables: 22.00
AIMD income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 21246.00
AIMD income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1599.00
AIMD income_statement (annual, 2025-12-31) — Reconciled Depreciation: 4780150.00
AIMD income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1202067.00
AIMD cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1000000.00
AIMD cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
AIMD cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -260.00
AIMD cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
AIMD income_statement (annual, 2025-12-31) — Research And Development: 7749772.00
AIMD income_statement (quarterly, 2025-12-31) — Research And Development: 2123258.00
AIMD balance_sheet (annual, 2025-12-31) — Retained Earnings: -67520328.00
AIMD balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -67520328.00
AIMD income_statement (annual, 2025-12-31) — Selling General And Administration: 6343547.00
AIMD income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2183920.00
AIMD balance_sheet (annual, 2025-12-31) — Share Issued: 7042675.00
AIMD balance_sheet (quarterly, 2025-12-31) — Share Issued: 7042675.00
AIMD cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1728055.00
AIMD cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 0.00